Hormones
1-minute read
Follow the links below to find trusted information about hormones.
Last reviewed: May 2018
Need more information?
These trusted information partners have more on this topic.
Top results
Is Menopausal Hormone Therapy (HRT) safe? - Australasian Menopause Society
Professor Rod Baber discusses the safety of menopausal hormone therapy (HRT).
Read more on Australasian Menopause Society website
What is Menopausal Hormone Therapy (HRT)? - Australasian Menopause Society
Professor Susan Davis discusses the basics of menopausal hormone therapy (HRT).The original series is available for download at https://www.youtube.com/playlist?list=PLAjwoYuItHS-4jvjL6gJgM7o-vpr0PVk6
Read more on Australasian Menopause Society website
Cancer Hormone Therapy - Information & Support - CanTeen
Hormonal therapies act by altering the production of hormones in the body and are most commonly used to treat breast cancer and prostate cancer.
Read more on CanTeen website
Thyroid gland and thyroid hormones - myDr.com.au
The thyroid gland produces thyroid hormones - the main ones being T3 (triiodothyronine) and T4 (thyroxine).
Read more on myDr website
Testosterone (male sex hormone) information | myVMC
Testosterone is the male sex hormone and one of a group of hormones known as androgens. It can be supplemented with testosterone replacement therapy.
Read more on myVMC – Virtual Medical Centre website
Menopausal hormone therapy (MHT)
Hormone replacement therapy (HRT), now more commonly known as menopausal hormone therapy (MHT), is not a quick fix for the challenge of menopause, but it can reduce troublesome symptoms.
Read more on myDr website
Hormone therapy | Cancer Australia
Hormones are naturally produced substances in the body that tell some cells and tissues how to behave and grow. Hormone therapy (also called endocrine therapy) aims to stop or slow the growth of certain types of cancer that use hormones to grow.These include breast, prostate and thyroid cancers.
Read more on Cancer Australia website
Injectable hormonal contraceptive
Depo Provera is a synthetic hormone (progestogen) that is given by injection every 3 months
Read more on WA Health website
Hormonal Treatment - Counterpart
Find information on the various hormonal treatments that can be used in the treatment of some types of breast cancer.
Read more on Counterpart - Women supporting women with cancer website
Growth hormone - Better Health Channel
Some athletes and bodybuilders wrongly believe that taking synthetic growth hormone will help build up their muscles.
Read more on Better Health Channel website
Top results
Gonadotrophin-releasing hormone antagonists versus GnRH agonist in subfertile couples undergoing assisted reproductive technology | Cochrane
Gonadotrophin-releasing hormone antagonists versus GnRH agonist in subfertile couples undergoing assisted reproductive technology
Read more on Cochrane (Australasian Centre) website
Gonadotrophin-releasing hormone antagonists in subfertile couples undergoing ovulation induction as part of an assisted conception program | Cochrane
Read more on Cochrane (Australasian Centre) website
Growth hormone in in-vitro fertilisation | Cochrane
Before starting an in-vitro fertilisation cycle, some women need help to ovulate and the use of growth hormone therapy may help these women. This aims to reduce the use of gonadotropin therapy to stimulate ovulation, a hormone that can cause multiple pregnancy. The review of trials found no evidence that growth hormone helps improve birth rates in women who are undergoing ovulation induction prior to in-vitro fertilisation. However there is some evidence of increased pregnancy and birth rates in women who are considered 'poor responders' to in-vitro fertilisation. More research is needed.
Read more on Cochrane (Australasian Centre) website
Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia | Cochrane
A systematic overview of randomised trials does not provide sufficient evidence to determine whether thyroid hormone treatment of preterm infants with transiently low thyroid hormone levels results in changes in neonatal outcomes or reductions in developmental impairments. Extremely premature infants frequently have transiently low thyroid hormone levels in the first weeks after birth. These low thyroid hormone levels are associated with an increased incidence of complications and death in the newborn period and longer term developmental impairments. Thyroid hormone therapy might prevent these problems. One small trial comparing thyroid hormone treatment to no treatment of infants with transiently low thyroid hormone levels reported no benefit from treatment of these infants. However, this is insufficient evidence to determine if thyroid hormone treatment is effective. Further research is needed.
Read more on Cochrane (Australasian Centre) website
Thyroid hormones for preventing neurodevelopmental impairment in preterm infants | Cochrane
No evidence from trials that thyroid hormone therapy is effective in preventing problems such as respiratory distress syndrome in preterm babies. Thyroid hormones are needed for the normal growth and maturity of the central nervous system, as well as the heart and lungs. Children born without sufficient thyroid hormones can develop serious mental retardation. It is believed that low levels of thyroid hormones in the first few weeks of life (transient hypothyroxinemia) in preterm babies born before 34 weeks may cause this abnormal development. The review of trials found no evidence that using thyroid hormones in preterm babies is effective in reducing the risk of problems caused by insufficient thyroid hormones.
Read more on Cochrane (Australasian Centre) website
Growth Hormone Deficiency Childhood | Australian Sports Anti-doping Authority - ASADA
Growth Hormone deficiency refers to a disorder of the hypothalamus or pituitary gland in which Growth Hormone production is impaired. Treatment of Growth Hormone deficiency is by supplementation with Growth Hormone, which is prohibited at all times in sport.What information is required for a Therapeutic Use Exemption (TUE) application?ASDMAC will not consider granting a TUE without the following information:
Read more on Australian Sports Anti-Doping Authority (ASADA) website
Recombinant growth hormone for idiopathic short stature in children and adolescents | Cochrane
There is some evidence that recombinant human growth hormone improves short term growth and (near) final adult height in children with idiopathic short stature.
Read more on Cochrane (Australasian Centre) website
Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants | Cochrane
A systematic review of the data from randomised controlled trials provides no evidence that routine thyroid hormone therapy is effective in preventing problems in preterm babies or improves their developmental outcomes. Thyroid hormones are needed for the normal growth and maturity of the central nervous system, as well as the heart and lungs. Children born without sufficient thyroid hormones can develop serious mental retardation. It is believed that low levels of thyroid hormones in the first few weeks after birth (transient hyperthyroxinaemia) in preterm babies born before 34 weeks may contribute to this abnormal development. The review of trials found no evidence that using thyroid hormones routinely in preterm babies is effective in reducing the risk of problems caused by transiently low levels of thyroid hormones.
Read more on Cochrane (Australasian Centre) website
Human growth hormone for treating burns and skin graft donor sites | Cochrane
Growth hormone is produced by the pituitary gland. For decades, it could only be obtained by extraction from pituitary glands but more recently it has been produced through genetic engineering and made available for therapy as recombinant human growth hormone (rhGH). The aim of this review was to determine the effects of rhGH when used to treat burns and skin graft donor sites and to determine its safety compared with other treatments.
Read more on Cochrane (Australasian Centre) website
Adjuvant gonadotropin-releasing hormone analogues for chemotherapy induced premature ovarian failure in premenopausal women | Cochrane
Adjuvant gonadotropin-releasing hormone analogues for chemotherapy induced premature ovarian failure in premenopausal women
Read more on Cochrane (Australasian Centre) website
